Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Intec Pharma Announces Filing of 2020 Annual Report on Form 10-K
Intec Pharma LtdMarch 17, 2021 GMT
JERUSALEM , March 16, 2021 (GLOBE NEWSWIRE) Intec Pharma Ltd. (NASDAQ: NTEC) (“Intec” or “the Company”) today announces that it has filed its annual report on Form 10-K for the year ended December 31, 2020 with the U.S. Securities and Exchange Commission. A copy of the annual report is available on Intec’s website, www.intecpharma.com, by selecting “Investors” and then “Financials” and “SEC Filings”.
You may request a copy of the Company’s Form 10-K, at no cost to you, by writing to the Chief Financial Officer of the Company at 12 Hartom Street, Har Hotzvim, Jerusalem 9777512, Israel or by calling the Company at +972 (2) 586 4657.
MedCity News
Grand Rounds strikes merger with Doctor on Demand
In another big tie-up between a telehealth and digital health company, Grand Rounds and Doctor on Demand reached a merger agreement. Grand Rounds CEO Owen Tripp will serve as CEO of the combined business.
Shares1
When Teladoc closed its $18.5B acquisition of Livongo, it set the stage for more mergers to come. Now, two more established digital health companies are pairing up.
On Tuesday, Grand Rounds announced plans to merge with Doctor on Demand, creating a company that would build on Grand Rounds’ care navigation services with the latter’s telehealth platform.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Elixinol to Acquire 100% of CannaCare Health
Elixinol GlobalMarch 17, 2021 GMT
Acquisition positions Elixinol as a leading pan-European CBD business and accelerates path to profitability
Management to discuss transaction and provide business update at the Cannabis Investing Forum on March 18
WESTMINSTER, Colo., March 17, 2021 (GLOBE NEWSWIRE) Elixinol Global Limited (Elixinol or the Company) (ASX:EXL; OTCQB:ELLXF) is pleased to announce that it has entered into a binding agreement for its subsidiary (Elixinol B.V.) to acquire all of the issued share capital of CannaCare Health GmbH (CannaCare), a company incorporated in Germany (Proposed Transaction). The vendors of CannaCare are Mr Frank Otto, Ms Annette-Rosa Oplesch and an entity associated with Mr Michael Oplesch (Vendors). The Proposed Transaction is subject to the satisfaction of certain conditions precedent, the details of whic
Submit Release
CFAW Dealmaker and Office of the Year Awards March 17, 2021 (PRLEAP.COM) Business News At the annual awards, CFAW announced Alexander Petersen as M&A Dealmaker for 2020 and the Los Angeles Office was awarded Office of the Year.
Alexander earned the prestigious award after closing multiple middle-market mergers and acquisition transactions in 2020. CFAW s Los Angeles office, headed by Peter Heydenrych, Principal and Managing Director, was awarded Office of the Year for 2020. Peter and his team have been successfully serving middle market business owners since 1991 and as former Chairman and CEO of CFAW, he provides key leadership to our organization , said Jim Zipursky, Chairman and CEO of Corporate Finance Associates Worldwide.
Press release content from Business Wire. The AP news staff was not involved in its creation.
INTEC PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Intec Pharma Ltd. - NTEC
March 17, 2021 GMT
NEW ORLEANS (BUSINESS WIRE) Mar 17, 2021
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Intec Pharma Ltd. (“the Company”) (NasdaqCM: NTEC) to Decoy Biosystems, Inc. pursuant to which Intec shareholders are expected to only own approximately 25% of the combined company, on a fully diluted basis. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company.